GJA1 and chronic kidney disease: Targeted delivery of siRNA through connexin 43 exosome-mimicking chitosan nanoparticles is also being explored [151], which may offer insight into targeting CKD tissue with over-expressed connexin 43 [4] and/or regulating connexin 43 function in cellular NAD retention [6].